Immune profiling uncovers memory t-cell responses with a th17 signature in cancer patients with previous sars-cov-2 infection followed by mrna vaccination

HIGHLIGHTS

• who: Miriam Echaide and colleagues from the Navarra-UPNA-IdISNA, Irunlarrea, Pamplona, Spain have published the article: Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination, in the Journal: Cancers 2022, 14, 4464. of /2022/
• what: The overall aim was to test the efficacy of current mRNA_vaccines to raise antibody and T-cell responses in cancer patients compared to healthy donors and characterize the immunological profile of these responses. The authors demonstrate in the study that cancer patients showed even . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.